153
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

FDG-PET/CT response assessment with qualitative Lugano criteria outperforms change in SUVmax as a predictive biomarker in frontline treatment of mantle cell lymphoma

ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1870-1874 | Received 03 Apr 2023, Accepted 10 Jul 2023, Published online: 25 Jul 2023
 

Authors’ contribution

DARG, JCM, BAS, and NLB designed the research. DARG, JCM, BRC, and MPW collected the data. DARG, JCM, and NW analyzed the data. DARG, JCM, MPW, BAS, and NLB wrote the manuscript.

Disclosure statement

NLB receives research funding from Autolus, Celgene/Bristol Myers-Squibb, Forty-Seven, Janssen, Kite/Gilead, Merck, Millennium, and Pharmacyclics, and serves as a consultant/advisor for ADC Therapeutics, Genentech/Roche, and Seattle Genetics. BAS serves as a consultant for Curium Pharma, Lantheus Medical, Capella Imaging, and GE Healthcare.

Additional information

Funding

The authors received no specific funding for this work.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.